Esperoct

Medicinal product

(Invented) name

Esperoct

Active substance (s)

Žmogaus VIII (rDNR) koaguliacijos faktorius

Strength

4000 TV

Pharmaceutical form

milteliai ir tirpiklis injekciniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B02BD02, Coagulation factor VIII

Marketing authorisation holder

Novo Nordisk A/S, Danija

Date of authorisation

2019-06-20

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder and solvent for solution for injection	1 vnt.
Žmogaus VIII (rDNR) koaguliacijos faktorius	4000 TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
111757	97872	1097872	flakonas	milteliai, tirpiklio užpildytas švirkštas (4 ml), stūmoklio strypelis ir flakono adapteris N1		Receptinis	EU/1/19/1374/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2019-06-20	Registruotas